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We assessed the expression of Bcl-2 family members at both mRNA and protein levels as well as the Caspase-3 activity, in order
to investigate the occurrence of apoptosis in hippocampus of STZ-induced diabetic rats. We selected twenty-four Wistar rats; half
of them were made diabetic by intraperitoneal injection of a single 60mg/kg dose of streptozotocin (STZ, IP), while the others
received normal saline and served as controls. The expressions of Bcl-2, Bcl-xL, and Bax mRNA and proteins were measured using
RT-PCR and western blotting, respectively. Caspases-3 activity was determined by using the Caspase-3/CPP32 Fluorometric Assay
Kit. The result showed that mRNA and protein levels of Bcl-2 and Bcl-xL were lower in hippocampus of diabetic group than that of
thecontrolgroup,whereasexpressionsofBaxinhippocampusofdiabeticratswerehigherthanthatofcontrolsatbothmRNAand
protein levels (P<. 01). Hyperglycemia was found to raise 6.9-fold hippocampal caspase-3 activity in diabetic group compared
with control group (P<. 001). Therefore, the induction of diabetes is associated with increased ratios of Bax/Bcl-2, Bax/Bcl-xL,
and increased caspase-3 activity in hippocampus which shows that apoptosis is favored in hippocampal region.
Copyright © 2008 Iraj Jafari Anarkooli et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Diabetes mellitus is one of the most severe problems
global, which is rising signiﬁcantly. At the present, the
WHO accounts 177 million patients with diabetes, while
this number is expected to double in 2030 [1]. Diabetes
mellitus is a heterogeneous metabolic disorder diagnosed
by hyperglycemia resulting from impaired insulin secretion,
resistance to insulin action, or both [2]. Hyperglycemia,
which occurs under the diabetic condition, is often asso-
ciated with complications, such as cardiovascular disease,
renal failure, retinopathy and peripheral, and autonomic
neuropathy [3, 4]. In recent years, it has been suggested
that diabetes also aﬀects the central nervous system [5,
6]. Within the central nervous system, the hippocampus
is considered as a particular target for changes related to
diabetes [7]. Hippocampus is a part of limbic system that
serves as a critical integration center for cognitive functions
such as learning and memory in the mammalian brain
[8]. It has been reported that impairments in memory,
learning, and cognition are more common in diabetic
people than in nondiabetic ones. In type-1 diabetes mellitus,
hippocampal neurons are extremely vulnerable [9–14]. Little
is known about the mechanism by which hyperglycemia
aﬀects neurons [15].
Apoptosiscouldbeproposedasapossiblemechanismfor
hyperglycemia-induced hippocampal neuronal cell death. It
has been revealed that is apoptosis implicated in several
neurodegenerativedisorderslikeAlzheimer’sdisease,Parkin-
son’s disease, Huntington’s disease, and amyotrophic lateral
sclerosis [11, 16]. Apoptosis is a gene-regulated occurrence
characterized by special morphological features, including
condensation of chromatin, shrinkage of cell and nucleus,
membrane blebbing, and DNA fragmentation [17]. Several2 Experimental Diabetes Research
factors are contributed in apoptosis, but the key elements
are categorized in two main families of proteins including
caspase enzymes and Bcl-2 family [18]. Caspase enzymes are
working as a cascade and caspase 3 is the most important
member of this family which plays an eﬀective role in
apoptosis of neurons of central nervous system [19]. Bcl-2
familyisasetofcytoplasmicproteinsthatregulateapoptosis.
The two main groups of this family, Bcl-2 and Bax proteins,
are functionally opposed: Bcl-2 and Bcl-xL act to inhibit
apoptosis, whereas Bax counteracts this eﬀect [19, 20].
In this study, we therefore assessed the expression of Bcl-
2familymembersatbothmRNAandproteinlevelsaswellas
the Caspase-3 activity, in order to investigate the occurrence
of apoptosis in hippocampus of STZ-induced diabetic rats.
2. MATERIALS AND METHODS
We selected twenty-four male Wistar rats weighing (200–
250g) for this study. Animals were randomly divided into
two groups (n = 12 in each group): the control (C) and
diabetic (D) groups. They were kept in the animal house
(AvicennaResearchinstitute,MashhadUniversityofMedical
Sciences, Mashhad, Iran) for one week for proper acclima-
tization before starting the experiment under controlled
condition of illumination (12 hours light/12 hours darkness)
and temperature 23 ± 2◦C. They were housed under ideal
laboratory conditions, maintained on standard pellet diet
and water ad libitum throughout the experimental period.
All procedures were in accordance with the Guide for the
Care and Use of Laboratory Animals of Mashhad University
of Medical Sciences, Iran.
Diabetes was induced in overnight fasted experimental
group by a single intraperitoneal injection of STZ (Sigma,
60mg/kg body weight) dissolved in normal saline, while the
control group was injected with the normal saline only [21].
Three days after administration of STZ, the tail vein blood
glucose level was measured in all animals. Blood glucose
l e v e l so f2 5 0m g / d la n da b o v ew e r ec o n s i d e r e dd i a b e t i c[ 22].
At the end of the eighth week, we measured weight and
blood glucose level of rats. Then, animals were anesthetized
with chloroform and the skull was open along the midline
and the brain was removed and placed on an ice-cooled
cutting board. The meninges were carefully removed and
hippocampus was dissected from hemispheres, snap frozen
in liquid nitrogen and stored at −70◦C for extraction of
DNA, RNA, and protein.
2.1. IsolationoftotalRNAandsynthesisofcDNA
RNA was isolated from processed hippocampal tissue of
rats using TriPure Isolation Reagent (Roche, Germany)
according to the manufacturer instructions. Total RNA was
reverse transcribed (RT) into cDNA with MBI RevertAid
(Fermentase, Life Sciences, Lithuanian) according to the
manufacturers instructions, and cDNA samples were stored
at –20◦C.
2.2. RT-PCR
A semiquantitative reverse transcriptase polymerase chain
reaction (RT-PCR) was carried out to determine the levels
of Bcl-2, Bcl-xL, and Bax mRNA expressions. The RT-PCR
mixture (ﬁnal volume of 20µL) contained 3µL of cDNA,
10µL of Qiagen Multiplex PCR Master Mix 2x (Qiagen,
Germany) and 10pmols of each complementary primer
speciﬁc for Bcl-2, Bcl-xL, and Bax sequences as well as
for GAPDH (Glyceraldehydes-3-phosphate dehydrogenase;
GAPDH gene) sequence as an internal control (Table 1).
The samples were denatured at 95◦C for 15 minutes, and
ampliﬁed using 40 cycles of 95◦C for 30 seconds, 60◦Cf o r
80 seconds, and 72◦C for 45 seconds for Bax gene and 5
cycles of 95◦C for 30 seconds, 62◦C for 60 seconds, and
72◦C for 30 seconds, as well as 25 cycles of 95◦Cf o r3 0
seconds, 64◦C for 80 seconds and 72◦C for 30 seconds for
Bcl-2 and Bcl-xL genes followed by a ﬁnal elongation at
72◦C for 3 minutes on a Corbett Research thermocycler
(Sydney,Australia).Theoptimalnumbersofcycleshavebeen
selected for ampliﬁcation of all three genes experimentally
so that ampliﬁcations were in the exponential range and
have not reached a plateau. Five microliters of the ﬁnal
ampliﬁcation product were run on a 3% ethidium-stained
agarose gel and photographed. Quantiﬁcation of the results
was accomplished by measuring the optical density of the
labeled bands, using the computerized imaging program
Kodack-1D (USA). The values were normalized to GAPDH
intensity levels.
3. WESTERN BLOT ANALYSIS
Tissues collected were homogenized with ice-cold homog-
enizing buﬀer (50mM Tris-HCl, 150mM NaCl, 1mM
EDTA, and 0.5mM Triton X-100, PH 7.4) and protease
inhibitor cocktail tablets (Roche, Germany). Proteins were
measured with Bio-Rad protein assay method. Hippocampal
protein lysates (50µg/well) were separated by SDS-PADE
(12.5%) under reducing conditions and transferred to a
polyvinylidene diﬂuoride (PVDF) membrane (Millipore,
USA). Membranes were treated with Attoglow western
blot system kit, according to the manufacturer protocol
(Biochain, USA). Brieﬂy, blots were blocked with blocking
buﬀer (5% not-fat dried milk in PBS). After blocking, blots
were incubated with anti-Bcl-2 polyclonal antibody (1/500,
v/v), anti-Bcl-xL polyclonal antibody (1/1000, v/v), and anti-
Bax polyclonal antibody (1/250, v/v) (Biovision, USA) for
20 hours at 4◦C. Blots were washed for 4 times with 0.1%
tween 20 in PBS and incubated with HRP conjugated-
secondary antibody (1/5000, v/v, Biochain, USA) for 1 hour
at room temperature. The Bcl-2, Bcl-xL and Bax protein
bands were visualized using enhanced chemiluminescnces
(ECL) method (Bioimaging, system, syngene, UK).
4. DETECTION OF CASPASE-3 ACTIVITY
Caspase-3 activity was determined using the Caspase-
3/CPP32 Fluorometric Assay Kit (K105) purchased from
Biovision, Inc. (Mountain View, Calif., USA). For each assay,Iraj Jafari Anarkooli et al. 3
MW C D
500bp
250bp Bax
(a)
MW C D
Bcl-2
(b)
MW C D
Bcl-xL
GAPDH
(c)
Figure 1: Semiquantative multiplex RT-PCR analysis of expressions of Bax, Bcl-2, and Bcl-xL genes in hippocampus of control (C) and
diabetic (D) groups of rat. (a) Ampliﬁcation of the Bax gene (263bp) compared with GAPDH gene (461bp). (b) Ampliﬁcation of the Bcl-2
gene (228bp) compared with GAPDH (461bp). (c) Ampliﬁcation of the Bcl-xL gene (357bp) compared with GAPDH (461bp).
Table 1: Primers used for RT-PCR method for Bcl-2, Bcl-xL, Bax, and GAPDH.
Genes Primers Product size
Bcl-2 F: 5 -CTG GTG GAC AAC ATC GCT CTG-3 
228bp
R: 5 -GGT CTG CTG ACC TCA CTT GTG-3 
Bcl-xL
F: 5 -AGG CTG GCGATG AGT TTG AA-3 
357bp
R: 5 -TGA AAC GCT CCT GGC CTT TC-3 
Bax F: 5 -TTCATC CAGGAT CGA GCA GA-3 
263bp
R: 5 -GCA AAG TAG AAG GCA ACG-3 
GAPDH F: 5 -GGCCAAGAT CAT CCA TGA CAA CT-3 
462bp
R: 5 -ACC AGG ACA TGA GCT TGA CAA AGT-3 
50µg of tissue cell lysate was used. Samples were read in
a ﬂuorimeter equipped (Jasco, FP-6200, Japan) witha 400-
nm excitation and a 505-nm emission ﬁlter. Fold-increasein
Caspase-3 activity was determined by comparing ﬂuores-
cenceof7-amino-4-triﬂuoromethylcoumarinincontroland
treated hippocampus with STZ.
5. STATISTICAL ANALYSES
All results are evaluated using the mean ±S.E.M. The results
were analyzed with Mann-Whitney and paired t-tests. A
probability level of P <.05 was considered signiﬁcant.
6. RESULTS
Bloodgluc osec onc entrationsofdiabeticratswer emor ethan
250mg/dl 3 days after the administration of STZ. Blood
glucose level at the end of the 8th week was signiﬁcantly
increased in diabetic group compared to nondiabetic (con-
trol) group (P<. 001).
At ﬁrst, both groups had similar body weights. Body
weight was increased in the control group at the end of
8 weeks; however, the diabetic groups lost body weight
compared to the control ones (P<. 01) (Table 2).
6.1. ExpressionofBax,Bcl-2,andBcl-xL genes
atmRNAlevel
As shown in Figure 1, expression of Bax was increased in
the hippocampus of STZ-induced diabetic group compared
to that of control group, while the expressions of Bcl-2 and
Bcl-xL were reduced. Furthermore, the Bax/Bcl-2 and the
Bax/Bcl-xL ratioswereincreasedinthehippocampusofSTZ-
induced diabetic group compared to control group (Figures
2(a) and 2(b)).
6.2. ExpressionsofBax,Bcl-2,andBcl-xL proteins
Aftereightweeks,theexpressionofproapoptoticBaxprotein
was enhanced in hippocampus of STZ-induced diabetic
group compared to control group of rats. On the other hand,
the expression of anti-apoptotic Bcl-2 and Bcl-xL proteins
were decreased in hippocampus of STZ-induced diabetic
group compared to the control group of rats (Figure 3).
6.3. EvaluationofCaspase-3activityin
tissueextracts
Caspase-3 activity was signiﬁcantly higher in STZ-induced
diabetic groupcomparedtothatofnondiabetic group(174.24 Experimental Diabetes Research
Table 2: Characteristic parameters of the control and STZ-diabetic rats. Values are shown as mean ±S.E.M. of 12 rats per group.
Control Diabetic
Initial body weight (g) 243.7 ±9.2 247.0 ±19.0
Final body weight (g) 306.0 ±10.4 198.1 ±21.0∗
Initial blood glucose (mg/dl) 109.4 ±5.6 106.9 ±6.3
Final blood glucose (mg/dl) 111.2 ±1.3 477.1 ±28.4∗∗
∗ P<. 01 versus control.
∗∗P<. 001 versus control.
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Figure 2: (a) Bax/Bcl-xL ratio of control (C) and STZ-induced
diabetic (D) groups of rat. Bar graph indicates the mean ±
S.E.M.#P<. 01, compared to the control group (n = 4 each group).
(b) Bax/Bcl-2 ratio of control (C) and STZ-induced diabetic (D)
groups. Bar graph indicates the mean ± S.E.M.#P<. 05, compared
to control group (n = 4 each group).
± 36 versus 25 ± 10.25, P<. 001). Hyperglycemia was found
to increase 6.9-fold hippocampal tissue caspase-3 activity in
diabetic group compared with nondiabetic group (Figure 4).
7. DISCUSSION
Despite of extensive investigations, the mechanism(s) acti-
vatingapoptoticpathwaysinthediabeticbrainhavenotbeen
completely understood [23]. In the present study, we showed
theeﬀectsofhyperglycemiaontheexpressionofBcl-2family
proteinlevelsandCaspase-3activityinhippocampusofSTZ-
induced diabetic rats.
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Figure 3: Western blot analysis to determine the expression of Bax,
Bcl-2 and Bcl-xL in extracts from hippocampus of control (C) and
diabetic (D) groups of rat.
Our results showed that after 8 weeks, Bax expression
was considerably increased in hippocampus of STZ-induced
diabetic rats at both mRNA and protein levels, while the
expressions of Bcl-2 and Bcl-xL were signiﬁcantly reduced at
both mRNA and protein levels. Furthermore, Bax/Bcl-2 and
Bax/Bcl-xL ratios, a main index of apoptotic cell death, were
signiﬁcantly increased; signifying hyperglycemia-induced
apoptosis in hippocampus of STZ-induced diabetic rats
could possibly be mediated by the mitochondrial pathway
[24].
Other studies have demonstrated that diabetes induces
apoptosis in central nervous system as well as in neuronal-
related tissues, including peripheral nervous system, gan-
glions, and retina [11, 25, 26]. Several experimental models
support that overexpression of Bax can induce apoptosis in
cells both in vivo and in vitro [11, 27]. In addition, the apop-
tosis has been reported in neuroblast cell cultures treated
with diabetic human sera [28]. Shariﬁ et al. showed that
the excess concentration of glucose resulted in an increase in
Bax expression protein and then induced apoptosis in PC12
cells [15]. Apoptosis and decrease in Bcl-2 expression were
detectedinprimaryneuronsofdorsalrootganglionofspinal
cord in diabetic rats [29, 30].
In this study, we were able to reveal the activation
of proapoptotic proteins and suppression of antiapoptoticIraj Jafari Anarkooli et al. 5
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Figure 4: Caspase-3 activity in hippocampal tissues of control (C)
and STZ-induced diabetic (D) rat groups. Bar graph indicates the
mean ± S.E.M.#P<. 001, compared to the control group (n = 4
each group). Fold-increasein Caspase-3 activity was determined by
comparing ﬂuorescence of 7-amino-4-triﬂuoromethyl courmarin
in control and treated hippocampus with STZ.
proteins in hippocampus of STZ-induced diabetic rats at
both mRNA and protein levels. There are two classes of
regulatory proteins in Bcl-2 family that substantiate opposite
eﬀects on apoptosis: the antiapoptotic members including
Bcl-2 and Bcl-xL which protect cells against some forms
of apoptosis, and proapoptotic members including Bax,
bak, and Bcl-xS which progress programmed cell death.
Apoptoticsignalsconvergetowardacommondeathpathway,
for which caspases perform apoptosis and the Bcl-2 family
proteins regulate it [31] .T h e r ei sa na b s o l u t ee v i d e n c e
that three main signals cause the release of apoptogenic
mitochondrial mediators including a proapoptotic member
of the Bcl-2 family, elevated level of intracellular calcium,
and reactive oxygen species (ROS) or free radicals [32].
It has previously been revealed that both ROS and Nitric
Oxide (NO) can change mitochondrial membrane potential
by opening the mitochondrial permeability transition pores
(mPTP), releasing cytochrome C and subsequent activation
of caspases 9 and 3 and ﬁnally causing cell death. Members
of the Bcl-2 family are known to be pro- and anti-apoptotic.
The balance between pro- and anti-apoptotic signals from
this family has a central role in the release of cytochrome C
and its succeeding consequences [33].
Furthermore, we found that the activity of caspases-3,
an eﬀector of apoptosis that plays a key role to link the
commitment and degradation phases [34], was signiﬁcantly
increased in hippocampus of STZ-induced diabetic rats
compared to nondiabetic rats, which is consistent with
previous studies [35–38].
Concurrent with our ﬁndings, Vincent et al. showed that
hyperglycemia observed in diabetes mellitus was associated
with oxidative stress-induced neuronal and Schwann cells
death via increased caspase 3 activity [39].
The precise mechanism through which this occurs in
hyperglycemia-induced apoptosis is not clear, but it has
shownthathyperglycemiacouldelevateROSinhippocampal
neuronalcellsresultedinelevationofintracellularcalciumin
neuronal cells [40]. Russell et al. showed excess mitochon-
drial ROS due to hyperglycemia depolarize mitochondrial
membranesfollowedbydecreaseinATPactivityandincrease
in Caspases-3 and 9 leading to Caspase-dependent apoptosis
[29]. Therefore, the induction of diabetes is associated
with increased ratios of Bax/Bcl-2 and Bax/Bcl-xL as well
as increase of caspase-3 activity in hippocampus which
shows that apoptosis is favored in hippocampal region. In
our experiment we also alternative methods such as, silver
staining for dark neurons, stereology, electron microscopy
and DNA laddering to support the results that obtained
with Bcl-2 family gene expression and caspase-3 activity
(Unpublished).
8. CONCLUSION
Taking together, it may ﬁnally be concluded that the STZ-
induced hyperglycemia causes hippocampal neuronal cell
death,inwhichapoptosisplaysanimportantrolepossiblyby
an increment in the Bax/Bcl-2 and Bax/Bcl-xL ratio, as well
as increasing caspase-3 activity. Diabetic-induced memory
and cognition deﬁcits may be partly due to a facilitation of
apoptosis andthisstudyprovidefurtherknowledgetomech-
anisms involved in STZ-induced apoptosis in hippocampus.
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